Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense

Journal of Clinical Investigation

Volumn 101, Issue 3, 1998, Pages 643-649

  Hayden, Frederick G ^a   Fritz, R Scott ^b   Lobo, Monica C ^a   Alvord, W Gregory ^c   Strober, Warren ^d   Straus, Stephen E ^d,e  

^a UNIVERSITY OF VIRGINIA   (United States)

^b SAIC FREDERICK INC   (United States)

^c Data Management Services Inc   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Influenza; Interferon ; Interleukin 6; Interleukin 8; Tumor necrosis factor

Indexed keywords

ALPHA INTERFERON; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; FEMALE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFLUENZA VIRUS A; MALE; NORMAL HUMAN; NOSE MUCUS; PRIORITY JOURNAL;

EID: 0032005791     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1355     Document Type: Article

References (28)

1. Benegar, K.B. 1992. Influenza virus infections and immunity: a review of human and animal models. Lab. Anim. Sci. 42:222-232.
2. Hayden, F.G., and J.M.J. Gwaltney. 1994. Viral infections. In Textbook of Respiratory Medicine. J.F. Murray and J.A. Nadel, editors. W.B. Saunders Co., Philadelphia. 977-1035.
3. Hayden, F.G., and P.A. Palese. 1997. Influenza virus. In Clinical Virology. D.D. Richmond, RJ. Whitley, and F.G. Hayden, editors. Churchill Livingstone, Inc., New York. 911-942.
4. Green, J.A., R.P. Charette, T.J. Yeh, and C.B. Smith. 1982. Presence of interferon in acute- and convalescent-phase sera of humans with influenza or an influenza-like illness of undetermined etiology. J. Infect. Dis. 145:837-841.
5. Houde, M., and D.J. Arora. 1990. Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase. Cell. lmmunol. 129:104-111.
6. Gong, J.-H., H. Sprenger, F. Hinder, A. Bender, A. Schmidt, S. Horch. M. Nain, and D. Gemsa. 1991. Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-α (TNF-α) gene expression and lipopolysaccharide-triggered TNF-α release. J. Immunol. 147:3507-3513.
7. Kaulbach, H.C., M.V. White, Y. Igarashi, B.K. Hahn, and M.A. Kaliner. Estimation of nasal epithelial lining fluid using urea as a marker. J. Allergy Clin. Immunol. 92:457-465.
8. Skoner, D.P., T. Whiteside, R. Herberman, W.J. Doyle, F.G. Hayden, and P. Fireman. 1993. Nasal interleukin levels during experimental influenza virus infection. J. Allergy Clin. Immunol. 91A:191. (Abstr.)
9. Peschke, T., A. Bender, M. Nain, and D. Gemsa, 1993. Role of macrophage cytokines in influenza A viral pneumonia. Immunobiology. 189:340-355.
10. Matsukura, S., F. Kokubu, H. Noda, H. Tokunaga, and M. Adachi. 1996. Expression of IL-6, IL-8 and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J. Allergy Clin. Immunol. 98:1080-1087.
11. Lehmann, C., H. Sprenger, M. Nain, M. Bacher, and D. Gemsa. 1996. Infection of macrophages by influenza A virus: characteristics of tumor necrosis factor-alpha (TNF-alpha) gene expression. Res. Virol. 147:123-130.
12. + T cell depletion. Reg. Immunol. 5:142-150.
13. Conn, C.A., J.L. McClellan, H.F. Maasab, C.W. Smitka, J.A. Majde, and M.J. Kluger. 1995. Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 268:R78-R84.
14. Vacheron, F., A. Rudent, S. Perin, C. Labarre, A.M. Quero, and M. Guenounou. 1990. Production of interleukin 1 and tumor necrosis factor activi-ties in bronchoalveolar washings following infection of mice by influenza virus. J. Gen. Virol. 71:477-479.
15. Hennet, T., H.J. Ziltener, K. Frei, and E. Peterhans. 1992. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J. Immunol. 149:932-939.
16. Van Snick, J. 1990. Interleukin-6: an overview. Annu. Rev. Immunol. 8: 253-278.
17. + T cells. J. Exp. Med. 185:461-469.
18. Weber, J.S., J.C. Yang, S.T. Topalian, D.R. Parkinson, D.S. Schwartzentruber, S.E. Ettinghausen, H. Gunn, A. Mixon, H. Kim, D. Cole, et al. 1993. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J. Clin. Oncol. 11:499-506.
19. Noah, T.L., F.W. Henderson, I.A. Wortman, R.B. Devlin, J. Handy, H.S. Koren, and S. Becker. 1995. Nasal cytokine production in viral acute upper respiratory infection of childhood. J. Infect. Dis. 171:584-592.
20. Zhu, Z., W. Tang, A. Ray, Y. Wu, O. Einarsson, M.L. Landry, J. Gwaltney, Jr., and J.A. Elias. 1996. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. J. Clin. Invest. 97:421-130.
21. Ruzek, M.C., A.H. Miller, S.M. Opal, B.D. Pearce, and C.A. Biron. 1997. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185:1185-1192.
22. Hoofnagle, J.H., and A.M. DiBisceglie. 1997. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336:347-356.
23. Orange, J.S., and C.A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer IFN-γ production and antiviral defense. J. Immunol 156:1138-1142.
24. Cousens, L.P., J.S. Orange, H.C. Su, and C.A. Biron. 1997. Interferonα/β inhibition of interleukin 12 and inierferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA. 94:634-639.
25. Spriggs, D.R., and S.W. Yates. 1992. Cancer chemotherapy: experiences with TNF administration in humans. In Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. B. Beutler, editor. Raven Press, Ltd., New York. 383-406.
26. Durum, S.K., and J.J. Oppenheim. 1993. Proinflammatory cytokines and immunity. In Fundamental Immunology, 3rd ed. W.E. Paul, editor. Raven Press, Ltd., New York. 802-835.
27. Choi, A.M.K., and D.B. Jacoby. 1992. Influenza virus A infection induces interIeukin-8 gene expression in human airway epithelial cells. FEBS (Fed. Eur. Biochem. Soc.) Lett. 309:327-329.
28. Peper, R.L., and C.H. Van. 1995. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb. Pathog. 19:175-183.